Alexandria Venture Investments, Llc Xilio Therapeutics, Inc. (XLO) insider trading activity

Alexandria Venture Investments, LLC is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 166,423 shares of XLO, which is worth approximately $213,021. The most recent transaction as insider was on Oct 26, 2021, when has been sold 166,423 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K

0% 3M change

0% 12M change

Total Value Held $213,021

Alexandria Venture Investments, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 26 2021	BUY Conversion of derivative security	-	166,423 Added 50.0%	166,423 Common Stock

Also insider at

OMIC

Singular Genomics Systems, Inc. Healthcare

> 10% Shareholder

VOR

Vor Biopharma Inc. Healthcare

> 10% Shareholder

SBTX

Silverback Therapeutics, Inc. Healthcare

> 10% Shareholder

VIGL

Vigil Neuroscience, Inc. Healthcare

> 10% Shareholder

AVI